Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis
ArticleAbstract: A topical nanofiber nitric oxide (NO) releasing patch (≈3.5 μmol NO/cm2/day for 20 days, NOP) was coPalabras claves:Autores:García C., García-Gómez R.G., Kampeerapappun P., López M., PATRICIO LOPEZ -JARAMILLO, Rincon M.Y., Silva S.Y., Smith D.J., Smith E., Vélez I.D.Fuentes:googlescopusDouble blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]
ArticleAbstract: Background: Cutaneous Leishmaniasis is a worldwide disease, endemic in 88 countries, that has shownPalabras claves:Autores:Buitrago A., Díaz H., López M., Mosquera H., Muñoz G., PATRICIO LOPEZ -JARAMILLO, Rueda L.C., Rueda-Clausen C.F., Silva S.Y., Silva-Sieger F.A., Smith D.J., Vélez I.D.Fuentes:googlescopus